Combination Therapy May Improve Outcomes for Advanced Bladder Cancer
Patients with immunotherapy-resistant non-muscle-invasive bladder cancer who received a novel combination treatment demonstrated improved 12-month response to treatment compared to standard treatment, according to a recent study published in Nature …